Cargando…
Noninvasive Fibrosis Marker Can Predict Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation
BACKGROUND/AIMS: Tumor recurrence after curative therapy is common for patients with hepatocellular carcinoma (HCC). As fibrosis and chronic inflammation contribute to the progression of HCC, we aimed to identify the predictive value of inflammatory and fibrosis markers for HCC recurrence after cura...
Autores principales: | Chung, Hyun Ah, Kim, Jeong-Han, Hwang, Young, Choi, Hong Seok, Ko, Soon Young, Choe, Won Hyeok, Kwon, So Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763530/ https://www.ncbi.nlm.nih.gov/pubmed/26831608 http://dx.doi.org/10.4103/1319-3767.173760 |
Ejemplares similares
-
The effect of nucleos(t)ide analogues on clinical outcomes of patients treated with transarterial chemoembolization and radiofrequency ablation for hepatitis B virus-related hepatocellular carcinoma
por: Park, Jae Min, et al.
Publicado: (2021) -
Comparison of Open versus Laparoscopic Approaches in Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation
por: Park, Yeshong, et al.
Publicado: (2023) -
A synchronous hepatocellular carcinoma and renal cell carcinoma treated with radio-frequency ablation
por: Lee, Yoon Serk, et al.
Publicado: (2014) -
Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
por: Kim, Jeong Han, et al.
Publicado: (2013) -
Radiofrequency ablation of recurrent thyroid cancers: anatomy-based management
por: Lee, Min Kyoung, et al.
Publicado: (2022)